摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-methylbenzo[a]phenazine | 20010-88-2

  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    19
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    25.8
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • Synthesis of Quinoxaline Analogues
    作者:Meng-Yang Chang、Tein-Wei Lee、Ru-Ting Hsu、Tzu-Lin Yen
    DOI:10.1055/s-0030-1260147
    日期:2011.10
    Substituted tricyclic or tetracyclic quinoxalines, tricyclic pyridoquinoxalines and bis-quinoxalines were synthesized in high yields starting from cyclic ketones by the α-bromination of cyclic ketones with N-bromosuccinimide (NBS) followed by condensation of the resulting α-bromo ketones with 1,2-diaminobenzene, 3,4-diaminopyridine, or 3,3′-diaminobenzidine. condensation - halogenation - tandem reactions
    从环酮开始,通过环酮与N-溴代琥珀酰亚胺(NBS)的α-溴化反应,然后将所得的α-溴代酮与1,2缩合,以高收率合成了取代的三环或四环喹喔啉,三环吡啶并喹喔啉和双喹喔啉。-二氨基苯,3,4-二氨基吡啶或3,3'-二氨基联苯胺。 缩合-卤化-串联反应-杂环-芳烃
  • Sulfur‐Catalyzed Oxidative Condensation of Aryl Alkyl Ketones with <i>o</i> ‐Phenylenediamines: Access to Quinoxalines
    作者:Le Anh Nguyen、Thi Thu Tram Nguyen、Quoc Anh Ngo、Thanh Binh Nguyen
    DOI:10.1002/adsc.202200527
    日期:2022.8.16
    While elemental sulfur has been largely used as oxidant or sulfurating agent, its role as a catalyst has not been developed. We report here its catalytic activity in the oxidative condensation of o-phenylenediamines with acetophenones in DMSO to provide quinoxalines. The method was also extended to α-tetralones, propiophenones (R=Me) as well as higher homologues (R=Et, n-Pr) in place of acetophenones
    虽然元素硫主要用作氧化剂或硫化剂,但其作为催化剂的作用尚未开发。我们在此报告其在邻苯二胺与苯乙酮在 DMSO中氧化缩合以提供喹喔啉的催化活性。该方法还扩展到 α-四氢萘酮、苯丙酮 (R=Me) 以及高级同系物 (R=Et, n -Pr) 以代替苯乙酮,从而产生了范围广泛的萘并喹喔啉和 3-取代的 2-芳基喹喔啉。
  • COMPOSITIONS AND METHODS FOR TREATING ALZHEIMERS DISEASE
    申请人:Puglielli Luigi
    公开号:US20120329789A1
    公开(公告)日:2012-12-27
    Pharmaceutical compositions for treating Alzheimer's disease are disclosed. The pharmaceutical compositions include a compound having the general formula: and a pharmaceutically acceptable carrier. Methods for treating Alzheimer's disease, inhibiting ATase I and/or ATase 2, reducing the activity of BACE1, reducing the level of amyloid β-peptide (Aβ), and/or reducing the level of APP intracellular domain peptide (AICD) by administering such compositions are also disclosed.
  • US8980884B2
    申请人:——
    公开号:US8980884B2
    公开(公告)日:2015-03-17
  • 4-Alkyl Derivatives of 1,2-Naphthoquinone
    作者:Louis F. Fieser、Charles K. Bradsher
    DOI:10.1021/ja01871a055
    日期:1939.2
查看更多